Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Palmitome analysis in parkinson´s disease

ABSTRACT: Proteomic analysis of the cortical palmitome derived from parkinson´s disease and control subjects

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Rebeca Mejías

PROVIDER: PXD037352 | JPOST Repository | Fri Oct 13 00:00:00 BST 2023

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Deamidation%20(NQ)Sites.txt	Txt
	Dioxidation%20(MW)Sites.txt	Txt
	WF-PD-10.raw	Raw
	WF-PD-11.raw	Raw
	WF-PD-12.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

RNAseq analysis of DPSC-derived neurons from Neurotypical control subjects and PWS subjects

Project description:RNAseq analysis of DPSC-derived neurons from Neurotypical control subjects and PWS subjects

| PRJNA740014 | ENA

Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains

Project description:Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains

| PRJNA835055 | ENA

Secretome of Bone Marrow Stroma-Derived Neural Progenitor Cells: Proteomic Analysis

Project description:We found the bone marrow stromal-derived neural progenitor cells secretome have the neural protection effect. Proteomic analysis was performed nn order to analyze the protection factor in the secretome. Keywords: Neural protection, secretome

2008-10-18 | GSE13242 | GEO

MicroRNA expression in human colon: Crohn's disease versus ulcerative colitis

Project description:Analysis of miRNA expression in colon biopsies from Crohn's disease (CD), ulcerative colitis (UC), and non-inflammatory bowel disease (IBD) control subjects.

2014-12-31 | GSE53867 | GEO

Salivary cytokine alterations in HIV infection part 2

2011-09-09 | GSE24064 | GEO

Salivary cytokine alterations in HIV infection part 1

Project description:Systemic and local (oral mucosal) immune responses in acutely infected HIV individuals before the initiation of HAART have not been well characterized. Protein microarrays were used to analyze saliva and plasma from HIV infected and HIV uninfected subjects to identify new biomarkers for HIV disease progression and pathogenesis. A 507 protein microarray was employed to provide a broad view of cytokines and chemokines in saliva and plasma in acutely HIV infected subjects as compared to uninfected subjects. A custom array derived from the initial results was refined to highlight those molecules with significant change relative to control subjects indicating the potential for biological impact.

2011-09-08 | E-GEOD-24037 | biostudies-arrayexpress

Salivary cytokine alterations in HIV infection part 2

Project description:A 507 protein microarray was employed to provide a broad view of cytokines and chemokines in saliva and plasma in acutely HIV infected subjects as compared to uninfected subjects. A 40 cytokine custom array derived from the initial results was refined to highlight those molecules with significant change relative to control subjects indicating the potential for biological impact. Systemic and local (oral mucosal) immune responses in acutely infected HIV individuals before the initiation of HAART have not been well characterized. Protein microarrays were used to analyze saliva and plasma from HIV infected and HIV uninfected subjects to identify new biomarkers for HIV disease progression and pathogenesis.

2011-09-08 | E-GEOD-24064 | biostudies-arrayexpress

Epigenome analysis of depressed and control subjects.

Project description:Epigenome analysis of depressed and control subjects.

| PRJNA515256 | ENA

APOE genotype or brain amyloid alters the plasma proteome in elderly subjects without dementia

Project description:Recent work has bolstered the possibility that peripheral changes may be relevant to Alzheimer’s disease pathogenesis in the brain. While age-associated blood-borne proteins have been targeted to restore function to the aged brain, it remains unclear whether other dysfunctional systemic states can be exploited for similar benefits. Here we investigate whether APOE allelic variation or presence of brain amyloid are associated with plasma proteomic changes and the molecular processes associated with these changes. Using the SOMAscan assay, we measured 1,305 plasma proteins from 53 homozygous, APOE3 and APOE4 subjects without dementia. We investigated the relationship of either the APOE-ε4 allele or amyloid positivity with plasma proteome changes by linear mixed effects modeling and ontology-based pathway and module trait correlation analyses. APOE4 is associated with plasma protein differences linked to atherosclerosis, tyrosine kinase activity, cholesterol transport, extracellular matrix, and synaptogenesis pathways. Independent of APOE4, we found that subjects likely harboring brain amyloid exhibit plasma proteome signatures associated with AD-linked pathways, including neurovascular dysfunction. Our results indicate that APOE4 status or presence of brain amyloid are associated with plasma proteomic shifts prior to the onset of symptoms, suggesting that systemic pathways in certain risk contexts may be plausible targets for disease modification.

2025-02-19 | GSE275392 | GEO

Machine learning-based plasma proteomic analysis identifies a novel disease-defining biomarkers

Project description:Recent advances in serum proteomic analysis tools have expanded our understanding of various diseases. To identify a novel disease-specific proteomic markers, we used the high-throughput proximity extension assay (PEA) platform to profile plasma proteins from 62 patients with atopic dermatitis (AD), or ulcerative colitis (UC) and 29 healthy subjects. Differentially expressed protein (DEP) analysis yielded 85 (20 unique) and 99 (14 unique) upregulated proteins in AD and UC, respectively, compared to healthy subjects. We integrated a machine-learning (ML) model and selected 24 proteins to distinguish between the diseases, which accurately predicted disease-defining biomarkers based on distinctive proteomic signatures and disease severity. Correlation analysis with disease severity identified upregulated ML-selected proteins such as CCL13, CCL26, CD70, CDON, LY6D and MMP1 in AD, and ITM2A and REG4 in UC. Among these identified proteins, we suggest CDON, CD70 and LY6D, which had highly correlated expression levels, as AD-specific biomarkers. Thus, our results provide insight into the application of ML algorithms for disease diagnosis, and our model may be expanded to other disease contexts.

2025-03-05 | PAD000005 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data